Brief: Galderma Receives U.S. FDA Approval For Restylane® Lyft™ For The Enhancement Of The Chin Profile

Galderma AG

05/11/2025 06:11

Nov 5 (Reuters) - GALDERMA GROUP AG GALD.S:

RECEIVES U.S. FDA APPROVAL FOR RESTYLANE® LYFT™ FOR THE ENHANCEMENT OF THE CHIN PROFILE

Source text: ID:nBwbDCdLga

Further company coverage: GALD.S

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))